Merlin inhibits CRL4-DCAF1 by directly binding to the DCAF1 substrate recruitment domain, and therefore, Merlin-deficient tumours have increased CRL4-DCAF1 activity [13]. This evidence concerns the gene NF2 and neoplasm.